博迅生物
(920504)
| 流通市值：2.69亿 | | | 总市值：7.07亿 |
| 流通股本：1651.09万 | | | 总股本：4333.31万 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 99,299,230.97 | 59,246,977.51 | 26,599,005.35 | 119,810,751.55 |
| 营业总成本 | 86,975,793.66 | 52,386,955.98 | 24,273,581.88 | 107,019,235.22 |
| 其他经营收益 | | | | |
| 营业利润 | 13,274,568.49 | 7,679,435.32 | 1,742,639.91 | 16,747,348.86 |
| 利润总额 | 13,246,073.41 | 7,679,671.48 | 1,742,876.07 | 16,336,245.58 |
| 净利润 | 11,893,072.67 | 6,906,235.15 | 1,495,622.01 | 14,914,704.14 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 11,893,072.67 | 6,906,235.15 | 1,495,622.01 | 14,914,704.14 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 166,765,331.52 | 169,493,777.87 | 163,957,724.81 | 171,677,640.37 |
| 非流动资产: | | | | |
| 非流动资产合计 | 96,850,887.71 | 87,005,173.97 | 98,374,181.11 | 99,682,154.61 |
| 资产总计 | 263,616,219.23 | 256,498,951.84 | 262,331,905.92 | 271,359,794.98 |
| 流动负债: | | | | |
| 流动负债合计 | 35,168,707.99 | 33,063,766.41 | 35,658,453.38 | 46,211,887.45 |
| 非流动负债: | | | | |
| 非流动负债合计 | 18,814,760.52 | 18,789,272.23 | 18,771,532.48 | 18,741,609.48 |
| 负债合计 | 53,983,468.51 | 51,853,038.64 | 54,429,985.86 | 64,953,496.93 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 209,632,750.72 | 204,645,913.2 | 207,901,920.06 | 206,406,298.05 |
| 股东权益合计 | 209,632,750.72 | 204,645,913.2 | 207,901,920.06 | 206,406,298.05 |
| 负债和股东权益合计 | 263,616,219.23 | 256,498,951.84 | 262,331,905.92 | 271,359,794.98 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 74,743,022.8 | 41,016,180.91 | 11,324,417.81 | 115,269,940.91 |
| 经营活动现金流出小计 | 95,670,607.84 | 53,780,981.02 | 24,749,263.98 | 94,723,025.36 |
| 经营活动产生的现金流量净额 | -20,927,585.04 | -12,764,800.11 | -13,424,846.17 | 20,546,915.55 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 198,746,113.99 | 160,414,416.89 | 77,343,759.7 | 329,980,566.24 |
| 投资活动现金流出小计 | 225,325,377.14 | 194,607,836.59 | 106,582,722.59 | 348,410,396.4 |
| 投资活动产生的现金流量净额 | -26,579,263.15 | -34,193,419.7 | -29,238,962.89 | -18,429,830.16 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | - | - | - | - |
| 筹资活动现金流出小计 | 8,666,620 | 8,666,620 | - | 2,826,303 |
| 筹资活动产生的现金流量净额 | -8,666,620 | -8,666,620 | - | -2,826,303 |
| 汇率变动对现金及现金等价物的影响 | -31,587.43 | -23,820.18 | -23,198.22 | 964.76 |
| 现金及现金等价物净增加额 | -56,205,055.62 | -55,648,659.99 | -42,687,007.28 | -708,252.85 |
| 期末现金及现金等价物余额 | 19,519,822.71 | 20,076,218.34 | 33,037,871.05 | 75,724,878.33 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -55,648,659.99 | - | -708,252.85 |